Clinical trials: Mifepristone
Cushing's Disease
Mifepristone in Children With Refractory Cushing's Disease
Study objectives are to obtain safety, pharmacokinetic, and pharmacodynamic data on the effect of mifepristone on glucose metabolism, body weight and the growth-hormone-IGF in children with refractory Cushing's disease.
- Trial name
- NCT01925092
- Testing
- mifepristone
- Where
- United States
- Sponsor
- Corcept Therapeutics
Hypercortisolism, Cushing Syndrome
Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing Syndrome
This retrospective, multi-center, chart review study will collect patient data from medical charts of pediatric patients who have been treated with Korlym for Cushing's syndrome.
- Trial name
- NCT03379363
- Where
- United States
- Volunteers
- 2 people
- Sponsor
- Corcept Therapeutics
Medical Abortion
Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion
National multi-center non interventional study aiming at investigating the effectiveness and safety of the combination mifepristone-misoprostol prescribed in Canada to women for medical termination of pregnancy at or before 63…
- Trial name
- MiMAC (NCT04905251)
- Testing
- Mifepristone-Misoprostol
- Where
- 6 sites in Canada
- Volunteers
- 129 people
- Sponsor
- Linepharma International LTD
Alzheimer's Disease
Mifepristone as Adjunctive Therapy in Alzheimer's Disease
The purpose of this study is to evaluate the effects of C-1073 (Mifepristone) on cognition in patients with Alzheimer's disease (AD) who are also taking an acetylcholinesterase inhibitor (Aricept, Exelon or Reminyl).
- Trial name
- NCT00105105
- Testing
- Mifepristone
- Where
- 21 sites in United States
- Volunteers
- 160 people
- Sponsor
- Corcept Therapeutics